Table 2 Penile length comparison in relative and percentage value [(Longer-Shorter)/Shorter].
From: HCG supplement did not accelerate tunica albuginea remodeling to facilitate penile growth
Penile length | Control | Anti-LOX | HCG | VED | Anti-LOX + VED | HCG + VED |
|---|---|---|---|---|---|---|
Anti-LOX (mm, %) | 4.58 (15%) | – | – | – | – | – |
HCG (mm, %) | 2.33 (8%) | 2.25 (7%) | – | – | – | – |
VED (mm, %) | 3.75 (12%) | 0.83 (2%) | 1.42 (4%) | – | – | – |
Anti-LOX + VED (mm, %) | 7.92 (26%) | 3.33 (9%) | 5.58 (17%) | 4.17 (12%) | – | – |
HCG + VED (mm, %) | 3.17 (10%) | 1.42 (4%) | 0.83 (2%) | 0.58 (2%) | 4.75 (14%) | – |
Anti-LOX + HCG + VED (mm, %) | 6.92 (22%) | 2.33 (7%) | 4.58 (14%) | 3.17 (9%) | 1.0 (3%) | 3.75 (11%) |